CHARACTERIZATION OF HEPARIN DOSE RESPONSE BY WEIGHT FOR VTE PROPHYLAXIS IN CRITICALLY ILL PATIENTS

被引：0

作者：

Aggarwal, Meera ^{[1
]}

Jarrell, Andrew

Gilmore, Vi ^{[2
]}

Aboagye, Jonathan ^{[3
]}

Haut, Elliott ^{[4
]}

Hobson, Deborah ^{[5
]}

Lau, Brandyn ^{[6
]}

Kickler, Thomas ^{[3
]}

Kraus, Peggy ^{[2
]}

Shaffer, Dauryne ^{[3
]}

Shermock, Kenneth ^{[2
]}

Streiff, Michael ^{[6
]}

Zheng, Gang ^{[3
]}

Kruer, Rachel ^{[3
]}

机构：

[1] Johns Hopkins Hlth Syst, Baltimore, MD USA

[2] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA

[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[4] Johns Hopkins Med Inst, Baltimore, MD 21205 USA

[5] Johns Hopkins Univ Hosp, Ellicott City, MD USA

[6] Johns Hopkins Univ, Baltimore, MD USA

来源：

CRITICAL CARE MEDICINE | 2019年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

954

引用

页数：1

共 50 条

[21] Continuation of therapeutic dose heparin for critically ill patients with COVID-19
Bradbury, Charlotte A.
Lawler, Patrick R.
McVerry, Bryan J.
Zarychanski, Ryan
REMAP C A P Investigators
[J]. INTENSIVE CARE MEDICINE, 2023, 49 (07) : 873 - 875
[22] Continuation of therapeutic dose heparin for critically ill patients with COVID-19
Charlotte A. Bradbury
Patrick R. Lawler
Bryan J. McVerry
Ryan Zarychanski
[J]. Intensive Care Medicine, 2023, 49 : 873 - 875
[23] CONTINUOUS LOW-DOSE HEPARIN INFUSION FOR CATHETER RELATED THROMBOSIS PROPHYLAXIS IN CRITICALLY ILL CHILDREN
Bujold, Kenneth
Halstead, E. Scott
Xavier, Frederico
[J]. PEDIATRIC BLOOD & CANCER, 2018, 65
[24] Delayed Dose of Pharmacological VTE Prophylaxis and VTE Incidence in Hospitalized Patients
Patil, S.
Karanth, S.
Ayad, M.
Vijhani, P.
Kaushal, S.
Sen, A.
Gopal, K.
Patel, B.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[25] Comparison of enoxaparin with unfractionated heparin (UFH) for venous thromboembolism (VTE) prophylaxis in medically ill dialysis patients.
Buckallew, Amanda
Buehler, Katie
Lee, Brian
[J]. PHARMACOTHERAPY, 2014, 34 (10): : E181 - E181
[26] Thromboprophylaxis in the critically Ill Low Molecular Weight Heparin versus unfractionated Heparin
Petros, S.
[J]. MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2016, 111 (01) : 55 - 56
[27] VTE Prophylaxis in Critically Ill Adults A Systematic Review and Network Meta-analysis
Fernando, Shannon M.
Tran, Alexandre
Cheng, Wei
Sadeghirad, Behnam
Arabi, Yaseen M.
Cook, Deborah J.
Moller, Morten Hylander
Mehta, Sangeeta
Fowler, Robert A.
Burns, Karen E. A.
Wells, Philip S.
Carrier, Marc
Crowther, Mark A.
Scales, Damon C.
English, Shane W.
Kyeremanteng, Kwadwo
Kanji, Salmaan
Kho, Michelle E.
Rochwerg, Bram
[J]. CHEST, 2022, 161 (02) : 418 - 428
[28] Prescription of low molecular weight heparin (LMWH) for prophylaxis against venous thromboembolism (VTE) in medical patients
Wardle, J
Webb, J
Holmes, J
Myers, B
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 7 - 7
[29] Efficacy of standard dose unfractionated heparin for venous thromboembolism prophylaxis in morbidly obese and non-morbidly obese critically Ill patients
Young R. Lee
Delilah D. Blanco
[J]. Journal of Thrombosis and Thrombolysis, 2017, 44 : 386 - 391
[30] WEIGHT-BASED HEPARIN NOMOGRAM FOR CRITICALLY ILL PATIENTS WITH HIGH BLEEDING RISK
Chui, Sai Ho
Dooley, Christopher
Huang, Ellen
Wilson, Sharon
Pajoumand, Mehrnaz
Stein, Deborah
[J]. CRITICAL CARE MEDICINE, 2015, 43 (12)

← 1 2 3 4 5 →